Patients with head and neck cancer may have impairment of some driving skillsSeptember 18, 2007A preliminary study suggests that patients with cancer in the head and neck region may have inferior performance in some driving skills compared with individuals without the disease, according to a report in the September issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. "Driving is a complex task that requires adequate cognitive, psychomotor and visuoperceptualmotor functions that work together. These functions can be compromised to a greater or lesser extent in patients with cancer in the head and neck region who have received cancer treatment," the authors write. Side effects from cancer treatment may reduce head and neck mobility and may cause cognitive impairment, pain and psychological distress predisposing patients to greater driving risks. Hon K. Yuen, Ph.D., O.T.R./L., of the Medical University of South Carolina, Charleston, and colleagues used a virtual reality driving simulator to evaluate the driving skills of 10 patients with head and neck cancer (average age 56) and 50 members of the community (average age 48). Researchers recorded average speed, average brake reaction time, steering variability (vehicle offset from the center of driving lane in inches), the total number of collisions and the score of the Simulator Driving Performance Scale, which assesses participants' driving behavior and skills including braking properly at intersections, driving within the speed limit, using mirrors properly and staying a safe distance from other vehicles. The median (midpoint) time between surgery and participation in the study was 26.6 months and the average time between cancer therapy and study participation was 20 months. The average brake reaction time and steering variability in the patients with cancer group were significantly longer (3,134.92 milliseconds vs. 2,299.8 milliseconds) and larger (271.26 inches vs. 46.45 inches), respectively, than those in the control group. There was not a significant difference between the two groups in average speed (21.8 miles per hour vs. 25.18 miles per hour), total number of collisions (1.1 vs. 1.4) or Simulator Driving Performance Scale scores. "This pilot study provides preliminary evidence indicating inferior driving performance in a group of patients with cancer in the head and neck region when compared with a community control group," the authors conclude. Further study is needed to investigate specific causes that may contribute to poor driving performance and the consequences this may have on driving in the real world for patients with cancer. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Neck Cancer Current Events and Neck Cancer News Articles PMH finding may help some tonsil cancer patients avoid chemotherapy Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. New laryngoscope could make difficult intubations easier A new tool developed by a Medical College of Georgia resident and faculty member may make it easier to place assisted breathing devices under difficult circumstances. Rare head and neck cancer linked to HPV, study finds An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. Curcumin may inhibit nicotine-induced activation of head and neck cancers Curcumin, the compound that gives curry powder its yellow/orange color, may inhibit the adverse effects of nicotine in patients with head and neck cancer who continue to smoke. Study finds 231 new genes associated with head and neck cancer A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States. U of T researchers create microchip that can detect type and severity of cancer U of T researchers have used nanomaterials to develop a microchip sensitive enough to quickly determine the type and severity of a patient's cancer so that the disease can be detected earlier for more effective treatment. Identification of highly radiosensitive patients may lead to side effect-free radiotherapy An international group of scientists has taken the first step on the road to targeting radiotherapy dosage to individual patients by means of their genetic characteristics. Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. Prevent periodontitis to reduce the risk of head and neck cancer Chronic periodontitis, a form of gum disease, is an independent risk factor for head and neck squamous cell carcinoma. This suggests the need for increased efforts to prevent and treat periodontitis as a possible means to reduce the risk of this form of cancer. Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson. More Neck Cancer Current Events and Neck Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||